Advances in human stem cell research and their applications to so-called regenerative medicine are going slower than expected, although significant progress has been made, says a new report on the subject by the European Science Foundation. The report recommends, among other things, the continued public support for this research and the clarification of the legal landscape with respect to patents.

Malén Ruiz de Elvira | 6 de julio de 2010

Stephen Minger is director of the biology laboratory of stem cells of the Wolfson Centre for Age-Related Diseases of King’s College London. He has been pioneer in embryonic stem cell research in the United Kingdom. In 2001 he obtained one of the two first licences that the British Human Fertilisation and Embryology Authority (HFSA) conceded for the derivation of embryonic stem cells. The following year, his group generated the first line of these cells in the United Kingdom, one of the first in the world.

Cristina Jiménez | 24 September 2009

Some seek the elixir of eternal youth. Others, the Holy Grail. And the laboratories of molecular biology and genetic engineering of the world are full of “Indiana Jones” in search of the key to decipher the behaviour of human cells. But after finding embryonic, adult and pluripotent stem cells, now scientist find themselves cruising in a sea of doubts.

Ànnia Monreal | 13 july 2009

The first focal point on the hazy world of stem cell research to treat genetic diseases has been found. Three Spanish teams have found the starting point with which to proceed and make genetic treatment and the solution a tangible binomial. At the start of the year its finding was sent to the journal Nature, which published the article at the beginning of June of this year.

Ànnia Monreal | 11 June 2009

A.R. | 3 JUNE 2009